Related Experiment Videos
C-reactive protein in simple community-acquired pneumonia
1Department of Respiratory Medicine, King's Cross Hospital, Dundee, Scotland.
Chest
|April 1, 1995
Summary
C-reactive protein (CRP) effectively distinguishes pneumonia from bronchitis, with higher levels in pneumonia. CRP also serves as a reliable indicator of treatment response in pneumonia patients.
Area of Science:
- Clinical Medicine
- Infectious Diseases
- Respiratory Medicine
Background:
- Community-acquired pneumonia and purulent bronchitis share overlapping symptoms.
- Accurate differentiation and monitoring of treatment response are crucial for effective patient management.
Purpose of the Study:
- To determine if C-reactive protein (CRP) is a sensitive diagnostic marker for pneumonia.
- To evaluate CRP's utility in assessing treatment response in pneumonia.
Main Methods:
- Retrospective review of 40 pneumonia and 20 purulent bronchitis cases.
- Serum CRP levels measured on admission and, for pneumonia, after 3-7 days of antibiotics.
- Comparison with traditional infection markers like temperature and white blood cell (WBC) count.
Main Results:
- CRP levels showed no overlap between pneumonia (>100 mg/L) and bronchitis (<10 mg/L) groups.
- Pneumonia patients had significantly higher initial CRP levels (217 mg/L) compared to bronchitis patients (18 mg/L).
- CRP levels decreased significantly after antibiotic treatment in pneumonia cases, indicating treatment response.
Conclusions:
- Serum CRP is a valuable adjunctive test for differentiating pneumonia from endobronchial infection.
- CRP serves as a sensitive marker for monitoring treatment response in pneumonia.